Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta-Reference-Cited by-同舟云学术

Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta

Published:2016-03-26 Issue:4 Volume:21 Page:410
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Hebda Michalina,Bajda Marek,Więckowska Anna,Szałaj Natalia,Pasieka Anna,Panek Dawid,Godyń Justyna,Wichur Tomasz,Knez Damijan,Gobec Stanislav,Malawska Barbara

Funder

Jagiellonian University Collegium Medicum

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/21/4/410/pdf

Reference65 articles.

1. World Alzheimer Report 2013 Journey of Caring: An Analysis of Long-Term Care for Dementia;Prince,2013

2. The worldwide economic impact of dementia 2010

3. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

4. Therapeutic strategies for Alzheimer's disease in clinical trials

5. Alzheimer's disease

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Pyrrole Derivatives as Multi-Target Agents for the Treatment of Alzheimer’s Disease: Microwave-Assisted Synthesis, In Silico Studies and Biological Evaluation;Pharmaceuticals;2024-09-04

2. Insights into synthesis, reactivity, and biological activity of N-isoindoline-1, 3-diones heterocycles: a systematic literature review;Journal of the Iranian Chemical Society;2024-04-24

3. Small Peptides Targeting BACE-1, AChE, and A-β Reversing Scopolamine-Induced Memory Impairment: A Multitarget Approach against Alzheimer’s Disease;ACS Omega;2024-03-04

4. Investigation into Anti-Alzheimer Activity of Newly Developed Phthalimide Derivatives in Experimental Animals;Pharmaceutical Chemistry Journal;2023-04

5. Anticholinesterase Agents For Alzheimer's Disease Treatment: An Updated Overview;Current Medicinal Chemistry;2023-02